nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—coronary artery disease	0.152	1	CbGaD
Pranlukast—Candesartan—Telmisartan—coronary artery disease	0.122	0.304	CrCrCtD
Pranlukast—Candesartan—Olmesartan—coronary artery disease	0.101	0.252	CrCrCtD
Pranlukast—Candesartan—Valsartan—coronary artery disease	0.0965	0.24	CrCrCtD
Pranlukast—Candesartan—Losartan—coronary artery disease	0.0821	0.204	CrCrCtD
Pranlukast—ABCC2—Olmesartan—coronary artery disease	0.0299	0.0943	CbGbCtD
Pranlukast—ABCC2—Telmisartan—coronary artery disease	0.0239	0.0754	CbGbCtD
Pranlukast—ABCC2—Pitavastatin—coronary artery disease	0.0239	0.0754	CbGbCtD
Pranlukast—ABCC2—Ezetimibe—coronary artery disease	0.0176	0.0556	CbGbCtD
Pranlukast—ABCC2—Simvastatin—coronary artery disease	0.0164	0.0516	CbGbCtD
Pranlukast—ABCC2—Lovastatin—coronary artery disease	0.0161	0.0505	CbGbCtD
Pranlukast—ABCC2—Pravastatin—coronary artery disease	0.0161	0.0505	CbGbCtD
Pranlukast—ABCC2—Atorvastatin—coronary artery disease	0.0146	0.046	CbGbCtD
Pranlukast—ABCC2—Furosemide—coronary artery disease	0.0136	0.043	CbGbCtD
Pranlukast—CYP2C9—Fenofibrate—coronary artery disease	0.0133	0.0418	CbGbCtD
Pranlukast—CYP2C9—Gemfibrozil—coronary artery disease	0.0106	0.0334	CbGbCtD
Pranlukast—CYP2C9—Clopidogrel—coronary artery disease	0.0092	0.029	CbGbCtD
Pranlukast—CYP3A4—Ticagrelor—coronary artery disease	0.00866	0.0273	CbGbCtD
Pranlukast—CYP2C9—Pitavastatin—coronary artery disease	0.00804	0.0253	CbGbCtD
Pranlukast—CYP2C9—Valsartan—coronary artery disease	0.00782	0.0246	CbGbCtD
Pranlukast—CYP3A4—Fenofibrate—coronary artery disease	0.00772	0.0243	CbGbCtD
Pranlukast—CYP3A4—Gemfibrozil—coronary artery disease	0.00617	0.0194	CbGbCtD
Pranlukast—CYP2C9—Rosuvastatin—coronary artery disease	0.00593	0.0187	CbGbCtD
Pranlukast—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00578	0.0182	CbGbCtD
Pranlukast—CYP2C9—Simvastatin—coronary artery disease	0.00551	0.0173	CbGbCtD
Pranlukast—CYP2C9—Lovastatin—coronary artery disease	0.00539	0.017	CbGbCtD
Pranlukast—CYP2C9—Pravastatin—coronary artery disease	0.00539	0.017	CbGbCtD
Pranlukast—CYP3A4—Clopidogrel—coronary artery disease	0.00535	0.0168	CbGbCtD
Pranlukast—CYP3A4—Eplerenone—coronary artery disease	0.00497	0.0157	CbGbCtD
Pranlukast—CYP2C9—Atorvastatin—coronary artery disease	0.00491	0.0155	CbGbCtD
Pranlukast—CYP2C9—Losartan—coronary artery disease	0.00449	0.0141	CbGbCtD
Pranlukast—CYP3A4—Enalapril—coronary artery disease	0.00443	0.014	CbGbCtD
Pranlukast—CYP2C9—cardial valve—coronary artery disease	0.00379	0.287	CbGeAlD
Pranlukast—CYP3A4—Ezetimibe—coronary artery disease	0.00345	0.0109	CbGbCtD
Pranlukast—CYP3A4—Rosuvastatin—coronary artery disease	0.00345	0.0109	CbGbCtD
Pranlukast—CYP3A4—Simvastatin—coronary artery disease	0.0032	0.0101	CbGbCtD
Pranlukast—CYP3A4—Pravastatin—coronary artery disease	0.00314	0.00987	CbGbCtD
Pranlukast—CYP3A4—Lovastatin—coronary artery disease	0.00314	0.00987	CbGbCtD
Pranlukast—CYP3A4—Atorvastatin—coronary artery disease	0.00286	0.00899	CbGbCtD
Pranlukast—CYP3A4—Losartan—coronary artery disease	0.00261	0.00822	CbGbCtD
Pranlukast—RNASE3—blood—coronary artery disease	0.0015	0.114	CbGeAlD
Pranlukast—IL5—blood—coronary artery disease	0.00136	0.103	CbGeAlD
Pranlukast—NFKB1—myocardium—coronary artery disease	0.00115	0.087	CbGeAlD
Pranlukast—TNF—blood—coronary artery disease	0.00105	0.0795	CbGeAlD
Pranlukast—NFKB1—heart—coronary artery disease	0.000801	0.0607	CbGeAlD
Pranlukast—NFKB1—cardiovascular system—coronary artery disease	0.000756	0.0573	CbGeAlD
Pranlukast—Candesartan—AGTR1—coronary artery disease	0.000729	0.482	CrCbGaD
Pranlukast—NFKB1—cardiac atrium—coronary artery disease	0.000685	0.0519	CbGeAlD
Pranlukast—NFKB1—blood—coronary artery disease	0.000598	0.0453	CbGeAlD
Pranlukast—CYSLTR1—blood—coronary artery disease	0.000587	0.0445	CbGeAlD
Pranlukast—Ospemifene—ESR1—coronary artery disease	0.000435	0.287	CrCbGaD
Pranlukast—Ospemifene—CYP2C19—coronary artery disease	0.000349	0.231	CrCbGaD
Pranlukast—ABCC2—blood—coronary artery disease	0.000235	0.0178	CbGeAlD
Pranlukast—CYP2C9—heart—coronary artery disease	0.00021	0.0159	CbGeAlD
Pranlukast—CYP2C9—cardiovascular system—coronary artery disease	0.000198	0.015	CbGeAlD
Pranlukast—CYP2C9—blood—coronary artery disease	0.000156	0.0118	CbGeAlD
Pranlukast—CYP3A4—blood—coronary artery disease	0.000119	0.00904	CbGeAlD
Pranlukast—NFKB1—Signaling Pathways—RPS6KB1—coronary artery disease	2.37e-06	2.08e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FGF2—coronary artery disease	2.36e-06	2.06e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—coronary artery disease	2.35e-06	2.06e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC27A1—coronary artery disease	2.33e-06	2.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ITGB3—coronary artery disease	2.31e-06	2.02e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CPT1B—coronary artery disease	2.29e-06	2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LCAT—coronary artery disease	2.29e-06	2e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—coronary artery disease	2.28e-06	1.99e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AKT1—coronary artery disease	2.27e-06	1.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—JAK2—coronary artery disease	2.26e-06	1.98e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CASP3—coronary artery disease	2.25e-06	1.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—coronary artery disease	2.25e-06	1.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PIK3CA—coronary artery disease	2.25e-06	1.96e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PPP2CA—coronary artery disease	2.25e-06	1.96e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA4—coronary artery disease	2.24e-06	1.96e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—coronary artery disease	2.24e-06	1.96e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2—coronary artery disease	2.24e-06	1.96e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MAPK1—coronary artery disease	2.23e-06	1.95e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GYG1—coronary artery disease	2.22e-06	1.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GATM—coronary artery disease	2.22e-06	1.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PFKM—coronary artery disease	2.22e-06	1.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GK—coronary artery disease	2.22e-06	1.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LDHA—coronary artery disease	2.22e-06	1.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.22e-06	1.94e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRKCD—coronary artery disease	2.21e-06	1.93e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	2.2e-06	1.93e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—coronary artery disease	2.19e-06	1.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PDHA1—coronary artery disease	2.17e-06	1.9e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCLM—coronary artery disease	2.17e-06	1.9e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—coronary artery disease	2.16e-06	1.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PIK3CA—coronary artery disease	2.16e-06	1.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C3—coronary artery disease	2.15e-06	1.89e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—coronary artery disease	2.13e-06	1.86e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AK1—coronary artery disease	2.12e-06	1.85e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCH1—coronary artery disease	2.12e-06	1.85e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	2.1e-06	1.84e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP11B2—coronary artery disease	2.1e-06	1.84e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TXNRD1—coronary artery disease	2.1e-06	1.84e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PIK3CA—coronary artery disease	2.08e-06	1.82e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—AKT1—coronary artery disease	2.08e-06	1.82e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC22A3—coronary artery disease	2.07e-06	1.81e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AKT1—coronary artery disease	2.07e-06	1.81e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HIF1A—coronary artery disease	2.06e-06	1.8e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGT—coronary artery disease	2.05e-06	1.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HADH—coronary artery disease	2.04e-06	1.78e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ARNTL—coronary artery disease	2.04e-06	1.78e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPAT—coronary artery disease	2.03e-06	1.77e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MDH2—coronary artery disease	2.03e-06	1.77e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—UGCG—coronary artery disease	2.03e-06	1.77e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLCD1—coronary artery disease	2.03e-06	1.77e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—coronary artery disease	2.01e-06	1.76e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—coronary artery disease	2.01e-06	1.76e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.01e-06	1.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—coronary artery disease	1.99e-06	1.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOA1—coronary artery disease	1.98e-06	1.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—coronary artery disease	1.98e-06	1.73e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KDR—coronary artery disease	1.97e-06	1.72e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.96e-06	1.71e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK14—coronary artery disease	1.95e-06	1.71e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PGM1—coronary artery disease	1.95e-06	1.71e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	1.93e-06	1.69e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA2—coronary artery disease	1.93e-06	1.69e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX2—coronary artery disease	1.93e-06	1.69e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ESR1—coronary artery disease	1.92e-06	1.68e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCG5—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX4—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SULT1A1—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HK1—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.91e-06	1.67e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—F2—coronary artery disease	1.89e-06	1.66e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FN1—coronary artery disease	1.89e-06	1.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CKB—coronary artery disease	1.89e-06	1.65e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PYGB—coronary artery disease	1.89e-06	1.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HADHA—coronary artery disease	1.88e-06	1.65e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6ST—coronary artery disease	1.88e-06	1.65e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NFKBIA—coronary artery disease	1.87e-06	1.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTA1—coronary artery disease	1.86e-06	1.63e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—coronary artery disease	1.84e-06	1.61e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LPA—coronary artery disease	1.84e-06	1.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—AKT1—coronary artery disease	1.83e-06	1.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KIT—coronary artery disease	1.81e-06	1.58e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLCB3—coronary artery disease	1.78e-06	1.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—COX5B—coronary artery disease	1.77e-06	1.55e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.77e-06	1.55e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.77e-06	1.55e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DLAT—coronary artery disease	1.77e-06	1.55e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.77e-06	1.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA5—coronary artery disease	1.77e-06	1.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—AKT1—coronary artery disease	1.76e-06	1.54e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—coronary artery disease	1.76e-06	1.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GSK3B—coronary artery disease	1.74e-06	1.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—P4HB—coronary artery disease	1.73e-06	1.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—coronary artery disease	1.72e-06	1.51e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CREB1—coronary artery disease	1.72e-06	1.51e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK1—coronary artery disease	1.72e-06	1.51e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.72e-06	1.5e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—coronary artery disease	1.72e-06	1.5e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	1.7e-06	1.49e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AKT1—coronary artery disease	1.7e-06	1.49e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL2—coronary artery disease	1.69e-06	1.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6R—coronary artery disease	1.68e-06	1.47e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.68e-06	1.47e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.68e-06	1.47e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.66e-06	1.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—coronary artery disease	1.66e-06	1.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HK2—coronary artery disease	1.6e-06	1.4e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.6e-06	1.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—VCAN—coronary artery disease	1.6e-06	1.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALDOA—coronary artery disease	1.59e-06	1.39e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—AKT1—coronary artery disease	1.58e-06	1.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—coronary artery disease	1.57e-06	1.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DCN—coronary artery disease	1.54e-06	1.35e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.54e-06	1.34e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FGF2—coronary artery disease	1.52e-06	1.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK1—coronary artery disease	1.51e-06	1.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.51e-06	1.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LCAT—coronary artery disease	1.51e-06	1.32e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—coronary artery disease	1.5e-06	1.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALDH2—coronary artery disease	1.5e-06	1.31e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3CA—coronary artery disease	1.49e-06	1.31e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA4—coronary artery disease	1.48e-06	1.29e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.46e-06	1.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	1.46e-06	1.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LIPC—coronary artery disease	1.46e-06	1.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP2C19—coronary artery disease	1.46e-06	1.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HBA1—coronary artery disease	1.46e-06	1.28e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—JAK2—coronary artery disease	1.46e-06	1.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOC3—coronary artery disease	1.45e-06	1.27e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LDLR—coronary artery disease	1.45e-06	1.26e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.44e-06	1.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.43e-06	1.25e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCLM—coronary artery disease	1.43e-06	1.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.43e-06	1.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.43e-06	1.25e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCLC—coronary artery disease	1.41e-06	1.24e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CETP—coronary artery disease	1.41e-06	1.24e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SDC1—coronary artery disease	1.4e-06	1.22e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.38e-06	1.21e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.38e-06	1.21e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.36e-06	1.19e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.34e-06	1.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HADH—coronary artery disease	1.34e-06	1.18e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—coronary artery disease	1.33e-06	1.17e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—coronary artery disease	1.32e-06	1.16e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.32e-06	1.15e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.32e-06	1.15e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.32e-06	1.15e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PIK3CA—coronary artery disease	1.31e-06	1.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CTGF—coronary artery disease	1.29e-06	1.13e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GOT2—coronary artery disease	1.28e-06	1.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.28e-06	1.12e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CASP3—coronary artery disease	1.28e-06	1.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA2—coronary artery disease	1.27e-06	1.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.27e-06	1.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX2—coronary artery disease	1.27e-06	1.11e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HK1—coronary artery disease	1.26e-06	1.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.26e-06	1.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.26e-06	1.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX4—coronary artery disease	1.26e-06	1.1e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HADHA—coronary artery disease	1.24e-06	1.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—coronary artery disease	1.24e-06	1.09e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.23e-06	1.08e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKT1—coronary artery disease	1.22e-06	1.07e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LPA—coronary artery disease	1.22e-06	1.06e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—coronary artery disease	1.21e-06	1.06e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.18e-06	1.03e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.17e-06	1.03e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA5—coronary artery disease	1.16e-06	1.02e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—coronary artery disease	1.16e-06	1.01e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.15e-06	1.01e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—P4HB—coronary artery disease	1.14e-06	9.99e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.14e-06	9.96e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.12e-06	9.81e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GGT1—coronary artery disease	1.1e-06	9.64e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GOT1—coronary artery disease	1.1e-06	9.64e-06	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—coronary artery disease	1.08e-06	9.47e-06	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AKT1—coronary artery disease	1.07e-06	9.35e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—VCAN—coronary artery disease	1.06e-06	9.25e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.05e-06	9.18e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DCN—coronary artery disease	1.02e-06	8.91e-06	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—coronary artery disease	9.94e-07	8.7e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALDH2—coronary artery disease	9.9e-07	8.67e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTP1—coronary artery disease	9.9e-07	8.66e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	9.81e-07	8.58e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMOX1—coronary artery disease	9.77e-07	8.54e-06	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK1—coronary artery disease	9.75e-07	8.53e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HBA1—coronary artery disease	9.65e-07	8.45e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LIPC—coronary artery disease	9.65e-07	8.45e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	9.65e-07	8.45e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2C19—coronary artery disease	9.65e-07	8.45e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CAT—coronary artery disease	9.64e-07	8.43e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOC3—coronary artery disease	9.59e-07	8.39e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LDLR—coronary artery disease	9.53e-07	8.34e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC9A1—coronary artery disease	9.42e-07	8.24e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTT1—coronary artery disease	9.42e-07	8.24e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOB—coronary artery disease	9.35e-07	8.18e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCLC—coronary artery disease	9.31e-07	8.15e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CETP—coronary artery disease	9.31e-07	8.15e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SDC1—coronary artery disease	9.21e-07	8.06e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—coronary artery disease	9.1e-07	7.96e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—LPL—coronary artery disease	8.93e-07	7.81e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX1—coronary artery disease	8.71e-07	7.62e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PSMA6—coronary artery disease	8.7e-07	7.61e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PSMB5—coronary artery disease	8.7e-07	7.61e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CTGF—coronary artery disease	8.5e-07	7.44e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CD36—coronary artery disease	8.49e-07	7.42e-06	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3CA—coronary artery disease	8.46e-07	7.4e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMGCR—coronary artery disease	8.42e-07	7.37e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GOT2—coronary artery disease	8.42e-07	7.37e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPP2CA—coronary artery disease	8.38e-07	7.33e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—coronary artery disease	8.04e-07	7.04e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.74e-07	6.78e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AGT—coronary artery disease	7.64e-07	6.69e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.51e-07	6.57e-06	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—coronary artery disease	7.49e-07	6.55e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—coronary artery disease	7.49e-07	6.55e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOA1—coronary artery disease	7.4e-07	6.48e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GOT1—coronary artery disease	7.27e-07	6.36e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GGT1—coronary artery disease	7.27e-07	6.36e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.09e-07	6.2e-06	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKT1—coronary artery disease	6.91e-07	6.04e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.53e-07	5.71e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARG—coronary artery disease	6.52e-07	5.71e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.47e-07	5.66e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.44e-07	5.63e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—coronary artery disease	6.43e-07	5.63e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CAT—coronary artery disease	6.35e-07	5.56e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOB—coronary artery disease	6.17e-07	5.4e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—coronary artery disease	6e-07	5.25e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—LPL—coronary artery disease	5.89e-07	5.15e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—coronary artery disease	5.86e-07	5.13e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX1—coronary artery disease	5.75e-07	5.03e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—coronary artery disease	5.61e-07	4.91e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CD36—coronary artery disease	5.6e-07	4.9e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.53e-07	4.84e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.3e-07	4.64e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—coronary artery disease	5.13e-07	4.49e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AGT—coronary artery disease	5.04e-07	4.41e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—coronary artery disease	4.94e-07	4.32e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOA1—coronary artery disease	4.88e-07	4.27e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARG—coronary artery disease	4.3e-07	3.76e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—coronary artery disease	4.24e-07	3.71e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—coronary artery disease	3.87e-07	3.38e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—coronary artery disease	3.7e-07	3.24e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.38e-07	2.96e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.16e-07	2.76e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKT1—coronary artery disease	2.58e-07	2.26e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.08e-07	1.82e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKT1—coronary artery disease	1.7e-07	1.49e-06	CbGpPWpGaD
